Reduced Thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer

European Urology

Volumn 42, Issue 5, 2002, Pages 464-468

  Goddard, Jonathan Charles ^a,b   Sutton, Christopher Derek ^a   Jones, Janet Louise ^a   O'Byrne, Kenneth John ^a   Kockelbergh, Roger Clive ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Bladder cancer; Image analysis; Immunohistochemistry; Thrombospondin

Indexed keywords

THROMBOSPONDIN 1; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INVASION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; BLADDER TUMOR; DISEASE COURSE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0036856030     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00372-X     Document Type: Article

References (13)

1. Napalkov P, Maisonneuve P, Boyle P: Epidemiology of bladder cancer. In: Pagano F. Fair WR, editors. Superficial Bladder Cancer. Oxford: Isis Medical Media Ltd; 1997. p. 1-23.
2. Ro JY, Staerkel GA, Ayala AG. Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am 1992;19:435-53.
3. Hassen W, Droller MJ. Current concepts in assessment and treatment of bladder cancer. Curr Opin Urol 2000;10:291-9.
4. Oosterlink W. The management of superficial bladder cancer. BJU Int 2001;87:135-40.
5. Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 1986;103:1635-48.
6. Frazier WA, Dixit VM, Galvin NJ, Rotwein PR. Structure of human thrombospondin: Complete amino acid sequence derived from cDNA. Semin Thromb Hemosta 1987;13:255-60.
7. DiPietro LA. Thrombospondin as a regulator of angiogenesis. EXS 1997;79:295-314.
8. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989;56:345-55.
9. Good DJ, Polverini PJ, Rastinejad F, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990;87:6624-8.
10. Volpert OV, Dameron KM, Bouck N. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumor-igenicity. Oncogene 1997;14:1495-502.
11. Campbell SC, Volpert OV, Ivanovich M, Bouck NP. Molecular mediators of angiogenesis in bladder cancer. Cancer Res 1998;58:1298-304.
12. Grossfeld GD, Ginsberg DA, Stein JP, et al. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 1997;89:219-27.
13. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994;265:1582-4.